170 results on '"Bett, Andrew J."'
Search Results
2. Profiling of hMPV F-specific antibodies isolated from human memory B cells
3. Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessment
4. Development and application of a higher throughput RSV plaque assay by immunofluorescent imaging
5. Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection
6. Optimization of the Helper-Dependent Adenovirus System for Production and Potency in vivo
7. Paracrine Expression of a Native Soluble Vascular Endothelial Growth Factor Receptor Inhibits Tumor Growth, Metastasis, and Mortality Rate
8. An Adenoviral Vector Deleted for All Viral Coding Sequences Results in Enhanced Safety and Extended Expression of a Leptin Transgene
9. A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens
10. Preclinical and clinical development of a dengue recombinant subunit vaccine
11. Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates
12. Split-Dose Administration Enhances Immune Responses Elicited by a mRNA/Lipid Nanoparticle Vaccine Expressing Respiratory Syncytial Virus F Protein
13. Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera
14. Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates
15. Split-Dose Administration Enhances Immune Responses Elicited by a mRNA/Lipid Nanoparticle Vaccine Expressing Respiratory Syncytial Virus F Protein.
16. An Efficient and Flexible System for Construction of Adenovirus Vectors with Insertions or Deletions in Early Regions 1 and 3
17. Upper and Lower Respiratory Tract Correlates of Protection Against RSV Following Vaccination of Non-Human Primates
18. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
19. DNA VACCINATION WITH ELECTROPORATION CAN BE CONTINUALLY BOOSTED AND OUTPERFORMS THE AD5 VECTOR PLATFORM: Abstract #67
20. [2] Techniques for human adenovirus vector construction and characterization
21. Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes
22. Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes
23. Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants
24. Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability
25. IMPre: An Accurate and Efficient Software for Prediction of T- and B-Cell Receptor Germline Genes and Alleles from Rearranged Repertoire Data
26. Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein
27. A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates
28. A Rapid and Improved Method to Generate Recombinant Dengue Virus Vaccine Candidates
29. Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cells
30. IMPre: An Accurate and Efficient Software for Prediction of T- and B-Cell Receptor Germline Genes and Alleles from Rearranged Repertoire Data.
31. Immunogenicity of a reduced-dose whole killed rabies vaccine is significantly enhanced by ISCOMATRIX™ adjuvant, Merck amorphous aluminum hydroxylphosphate sulfate (MAA) or a synthetic TLR9 agonist in rhesus macaques
32. A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge
33. An optimized SIV DNA vaccine can serve as a boost for Ad5 and provide partial protection from a high-dose SIVmac251 challenge
34. Low-Dose Penile SIVmac251 Exposure of Rhesus Macaques Infected with Adenovirus Type 5 (Ad5) and Then Immunized with a Replication-Defective Ad5-Based SIV gag/pol/nef Vaccine Recapitulates the Results of the Phase IIb Step Trial of a Similar HIV-1 Vaccine
35. Transcriptional profiling of vaccine‐induced immune responses in humans and non‐human primates
36. The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease
37. Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists
38. Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans
39. Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques
40. Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors
41. Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults
42. Synthesis and immunological activities of novel agonists of toll-like receptor 9
43. Robust, Vaccine-Induced CD8+ T Lymphocyte Response against an Out-of-Frame Epitope
44. Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults
45. Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge
46. Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag
47. Serotype Specificity of Adenovirus Purification Using Anion-Exchange Chromatography
48. Heterologous Human Immunodeficiency Virus Type 1 Priming-Boosting Immunization Strategies Involving Replication-Defective Adenovirus and Poxvirus Vaccine Vectors
49. Quantitative Adenovirus Neutralization Assays Based on the Secreted Alkaline Phosphatase Reporter Gene: Application in Epidemiologic Studies and in the Design of Adenovector Vaccines
50. Comparative Analysis of the Effects of Packaging Signal, Transgene Orientation, Promoters, Polyadenylation Signals, and E3 Region on Growth Properties of First-Generation Adenoviruses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.